There is a need to support the improvement of cross-cutting support technologies for drugs, biotherapies, vaccines and other therapeutic approaches, including transplantation, surgery, gene and cell therapy and nuclear medicine; to increase success in the drug and vaccine development process (including alternative methods to replace classical safety and effectiveness testing, e.g. the development of new methods); to develop regenerative medicine approaches, including approaches based on stem cells; to develop new biopharmaceuticals, including therapeutic vaccines; to develop improved medical and assistive devices and systems; to imp ...[+++]rove palliative therapies; to maintain and enhance the ability to combat disease and undertake medical interventions that depend on the availability of effective and safe antimicrobial drugs; and to develop comprehensive approaches to treat co-morbidities at all ages and avoid poly-pharmacy.

There is a need to support the improvement of cross-cutting support technologies for drugs, biotherapies, vaccines and other therapeutic approaches, including transplantation, surgery, gene and cell therapy and nuclear medicine; to increase success in the drug and vaccine development process (including alternative methods to replace classical safety and effectiveness testing, e.g. the development of new methods); to develop regenerative medicine approaches, including approaches based on stem cells; to develop new biopharmaceuticals, including therapeutic vaccines; to develop improved medical and assistive devices and systems; to imp ...[+++]rove palliative therapies; to maintain and enhance the ability to combat disease and undertake medical interventions that depend on the availability of effective and safe antimicrobial drugs; and to develop comprehensive approaches to treat co-morbidities at all ages and avoid poly-pharmacy.

10. Calls on the Member States to raise awareness more effectively of the potential risks attached to cosmetic surgery, and to better regulate the advertising of cosmetic surgery in order to ensure that patients are fully aware of the risks as well as the benefits; stresses that women should be made aware that breast implants need to be replaced after a period of time that varies from person to person, enabling them to assess risks more effectively;

Developments in medical technology -- whether the use of miniature robots for surgery, genetic therapies, growing replacement organs and tissues, new medicinal substances -- constitute the second issue as regards the national systems, particularly as regards health care [7].

If people are waiting too long for a hip replacement surgery, give us the opportunity to remedy it in the court system.

Second — and here I will go back to the analogy with the Canada Health Act — we can argue that a hip replacement in Alberta is somewhat similar to a hip replacement in Quebec.